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http://imaging.onlinejacc.org.969 Mechanical Abnormalities Detected With Conventional Echocardiography
Are Associated With Response and Midterm Survival in CRT
Adelina Doltra, Bart Bijnens, José M. Tolosana, Roger Borràs, Malek Khatib,
Diego Penela, Teresa Maria De Caralt, María Ángeles Castel, Antonio Berruezo,
Josep Brugada, Lluís Mont, Marta SitgesVINI : The signiﬁcant rate of nonresponders to cardiac resynchronization therapy (CRT) prompts the need
for better noninvasive prediction tools for identifying those who may beneﬁt from CRT.
VIDI : This retrospective observational, monocentric study of 200 CRT patients demonstrated that
correctable mechanical abnormalities on echocardiography (septal ﬂash, abnormal ventricular ﬁlling, or
exaggerated interventricular dependence) were independently predictive of rate and extent of CRT
response and increased survival. Clinical characteristics (creatinine level, left ventricular end-systolic
diameter, and New York Heart Association functional class IV) and myocardial viability also have an
inﬂuence.
VICI : With the incorporation of electrocardiographic, mechanical and clinical features, prediction tools
to identify responders to CRT continue to become more sophisticated. The derivation or validation of a
risk prediction score is likely to be an important next step in choosing appropriate candidates for this
intervention, as is conﬁrmation in a multicenter trial.980 n EDITORIAL COMMENT Selection for Cardiac Resynchronization Therapy: All in a Flash?
Thomas H. Marwick983 Handheld Ultrasound Versus Physical Examination in Patients Referred for
Transthoracic Echocardiography for a Suspected Cardiac Condition
Manish Mehta, Timothy Jacobson, Dawn Peters, Elizabeth Le, Scott Chadderdon,
Allison J. Allen, Aaron B. Caughey, Sanjiv KaulVINI : The bedside cardiac physical examination provides important preliminary data, which determines
whether additional testing is required for most patients presenting to the cardiology clinic or in the
hospital. However, improvements in portable imaging technology now provide a readily accessible
alternative to the physical exam that may be more standardized and less susceptible to error.
VIDI : In this observational study of 250 patients, handheld ultrasound provided a more accurate
diagnosis than physical examination for the majority of common cardiovascular abnormalities and led to a
projected cost savings of about $63.00 per patient.
VICI : With less emphasis being placed on the cardiac physical examination and the advent of newer
technologies, such as the handheld ultrasound, the physical examination is quickly becoming a dying art.
Additional studies are needed to determine whether the use of such portable imaging modalities, which
may be able to detect disease more effectively than the physical exam, improve long-term survival and
prove to be cost-effective in the long-term.CONTINUED ON PAGE A-10
A-10
OCTOBER 2014 VOLUME 7, NUMBER 10991 CMR-Veriﬁed Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction
in HFpEF
Mao-Yuan M. Su, Lian-Yu Lin, Yao-Hui E. Tseng, Chin-Chen Chang, Cho-Kai Wu,
Jiunn-Lee Lin, Wen-Yih I. TsengVINI : The evolution of cardiac magnetic resonance protocols has allowed for an improved ability to
better characterize differences in diastolic function. Such subtle differences can be especially important in
disease states such as systolic heart failure (SHF) and heart failure patients with preserved ejection
fraction (HFpEF), where pathophysiologic differences can inﬂuence prognosis and management.
VIDI : Using cardiac magnetic resonance T1 mapping technique to quantify diffuse myocardial ﬁbrosis in
40 patients with SHF, 62 patients with HFpEF, and 22 patients without heart failure, the authors report
that diffuse myocardial ﬁbrosis was signiﬁcantly associated with diastolic function in HFpEF but not
in SHF.
VICI : The ability to provide detailed in vivo tissue characterization using extracellular volume fraction
quantiﬁcation provides an important tool for determining preclinical diastolic dysfunction in heart failure.
Future studies will, without a doubt, assess the additional prognostic information added by this infor-
mation and whether therapies aimed at reverse remodeling, such as angiotensin-converting enzyme
inhibitors, can be begun even earlier based on cardiac magnetic resonance abnormalities.998 n EDITORIAL COMMENT Seeing the Unseen Fibrosis in Heart Failure
With Preserved Ejection Fraction
Michael Salerno1001 Progression to Overt or Silent CAD in Asymptomatic Patients With Diabetes Mellitus
at High Coronary Risk: Main Findings of the Prospective Multicenter BARDOT Trial
With a Pilot Randomized Treatment Substudy
Michael J. Zellweger, Michael Maraun, Hans H. Osterhues, Ulrich Keller,
Jan Müller-Brand, Raban Jeger, Otmar Pﬁster, Thilo Burkard, Friedrich Eckstein,
Stefanie von Felten, Stefan Osswald, Matthias PﬁstererVINI : Screening asymptomatic diabetics remains controversial and this data further adds to the existing
data supporting effective screening with myocardial perfusion single-photon emission computed
tomography (MPS).
VIDI : In this prospective multicenter outcome registry, 400 asymptomatic diabetic patients underwent
MPS at baseline, revealing that 22% had abnormal MPS ﬁndings with a cardiac event rate and were more
likely to have additional abnormalities on a repeat MPS scan. By comparison, patients with normal MPS
ﬁndings had a low rate of cardiac events. The treatment sub-study suggests that a combined invasive-
medical strategy for patients with abnormal MPS may reduce MPS abnormalities in those proceeding to an
invasive strategy (p < 0.001).
VICI : This outcomes study supports the effectiveness of MPS to serve as a screening tool for asymp-
tomatic diabetics. Additional research is warranted to examine if an MPS-guided strategy can improve
outcomes in asymptomatic diabetics.1011 n EDITORIAL COMMENT Screening, Diagnosis, and Management of CAD
in Asymptomatic Diabetic Patients
Peter A. McCullough, Poorya Fazel, James W. ChoiCONTINUED ON PAGE A-11
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OCTOBER 2014 VOLUME 7, NUMBER 101013 Sex-Related Differences of Coronary Atherosclerosis Regression Following
Maximally Intensive Statin Therapy: Insights From SATURN
Rishi Puri, Steven E. Nissen, Mingyuan Shao, Christie M. Ballantyne, Phillip J. Barter,
M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno,
Yu Kataoka, Stephen J. NichollsVINI : Although statins are now the cornerstone of our current antiatherosclerotic armamentarium,
conﬂicting data about their efﬁcacy in women due to under-representation has resulted in clinical
equipoise.
VIDI : This analysis of 765 men and 274 women reports the novel ﬁnding of sex-related differences of
serial coronary atheroma responses following 2 years of maximally intensive statin therapy in SATURN
(Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin).
Female sex independently associated with coronary atheroma regression. There was a signiﬁcant inter-
action between sex and treatment speciﬁcation, with rosuvastatin-treated women demonstrating the
greatest degree of plaque regression. For on-treatment low-density lipoprotein-cholesterol levels below
70 mg/dl, women demonstrated greater coronary atheroma regression than their male counterparts.
VICI : Although the overall parent study was negative with respect to differences in clinical outcomes,
this substudy of SATURN adds further evidence to the growing body of literature that there may be sex-
speciﬁc differences in response to statin therapy. It raises the question of whether additional prospective
statin trials, powered for outcomes, are needed in women.1023 n EDITORIAL COMMENT Women Are From SATURN and Men Are From an ASTEROID:
Deciphering the REVERSAL of Coronary Atheroma
Hector M. Garcia-Garcia, Carlos M. Campos, Patrick W. SerruysSTATE-OF-THE-ART
PAPERS
1025 Carotid Intima-Media Thickness and Plaque in Cardiovascular Risk AssessmentTasneem Z. Naqvi, Ming-Sum Lee1039 Brain Imaging Changes Associated With Risk Factors for Cardiovascular and
Cerebrovascular Disease in Asymptomatic Patients
Joseph I. Friedman, Cheuk Y. Tang, Hans J. de Haas, Lisa Changchien, Georg Goliasch,
Puneet Dabas, Victoria Wang, Zahi A. Fayad, Valentin Fuster, Jagat Narula1054 n EDITORIAL COMMENT The Future of CV Risk Prediction: Multisite Imaging to
Predict Multiple Outcomes
Michael J. BlahaIMAGING VIGNETTE 1057 CMR in the Assessment of Cardiac Masses: Primary Malignant Tumors
Antonio Esposito, Francesco De Cobelli, Gabriele Ironi, Paolo Marra, Tamara Canu,
Renata Mellone, Alessandro Del MaschioCONTINUED ON PAGE A-12
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OCTOBER 2014 VOLUME 7, NUMBER 10LETTERS TO THE EDITOR 1062 The Eustachian Ridge: Not an Innocent Bystander
Anna C. Kydd, Duncan McNab, Patrick A. Calvert, Stephen P. Hoole, Sushma Rekhraj,
Horst Sievert, Leonard M. Shapiro, Bushra S. Rana1063 Comparison of Coronary Magnetic Resonance and Computed Tomography
Angiography for Prediction of Cardiovascular Events
Ashraf Hamdan, Adelina Doltra, Alexander Huppertz, Ernst Wellnhofer,
Eckart Fleck, Sebastian Kelle1065 Annulus Instead of LVOT Diameter Improves Agreement Between
Echocardiography Effective Oriﬁce Area and Invasive Aortic Valve Area
Troy M. LaBounty, Rhonda Miyasaka, Stanley Chetcuti, Paul M. Grossman,
George Michael Deeb, Himanshu J. Patel, Anna Booher, Smita Patel,
David S. Bach1067 CMR-Based Characterization of Cardiac Amyloidosis
Andrea Barison, Pier Giorgio Masci, Giovanni Donato Aquaron REPLYJason N. Dungu, Lisa J. AndersonEDITOR’S PAGE 1069 Handheld Ultrasound: Accurate Diagnosis at a Lower Cost?
Thomas H. Marwick, Y. Chandrashekhar, Jagat Narula
